ATE184206T1 - Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport - Google Patents

Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport

Info

Publication number
ATE184206T1
ATE184206T1 AT95939502T AT95939502T ATE184206T1 AT E184206 T1 ATE184206 T1 AT E184206T1 AT 95939502 T AT95939502 T AT 95939502T AT 95939502 T AT95939502 T AT 95939502T AT E184206 T1 ATE184206 T1 AT E184206T1
Authority
AT
Austria
Prior art keywords
agent
electrotransport
ionic
hydrophobic site
active ingredients
Prior art date
Application number
AT95939502T
Other languages
English (en)
Inventor
Leslie A Holladay
Lynda G Treat-Clemons
Patricia Margaret Bassett
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE184206T1 publication Critical patent/ATE184206T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95939502T 1994-11-17 1995-11-03 Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport ATE184206T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34124694A 1994-11-17 1994-11-17

Publications (1)

Publication Number Publication Date
ATE184206T1 true ATE184206T1 (de) 1999-09-15

Family

ID=23336811

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95939502T ATE184206T1 (de) 1994-11-17 1995-11-03 Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport

Country Status (8)

Country Link
US (1) US6328728B1 (de)
EP (1) EP0793517B1 (de)
JP (1) JPH10509072A (de)
AT (1) ATE184206T1 (de)
AU (1) AU4129696A (de)
DE (1) DE69512083T2 (de)
ES (1) ES2137551T3 (de)
WO (1) WO1996015826A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2755372B1 (fr) * 1996-11-07 1998-12-24 Elf Aquitaine Dispositif d'ionophorese comportant au moins un ensemble electrode a membrane, pour l'administration transcutanee de principes actifs a un sujet
US7171264B1 (en) * 1999-05-10 2007-01-30 Genetronics, Inc. Intradermal delivery of active agents by needle-free injection and electroporation
AU4996300A (en) * 1999-05-10 2000-11-21 Gentronics, Inc. Method of electroporation-enhanced delivery of active agents
US6591133B1 (en) * 2000-11-27 2003-07-08 Microlin Llc Apparatus and methods for fluid delivery using electroactive needles and implantable electrochemical delivery devices
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US7141544B2 (en) * 2003-10-10 2006-11-28 Baxter International, Inc. Stabilization of pharmaceutical protein formulations with small peptides
EP1680178A4 (de) * 2003-10-31 2008-01-02 Alza Corp System und verfahren für die transdermale abgabe einer vakzine
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US7706873B2 (en) 2004-05-05 2010-04-27 Mario Ammirati System and method for controlled delivery of a therapeutic agent to a target location within an internal body tissue
US7527749B2 (en) 2004-10-18 2009-05-05 Georgia Tech Research Corporation Electrically conductive adhesives and methods of making
JP4646669B2 (ja) * 2005-03-30 2011-03-09 キヤノン株式会社 吐出用液体、吐出方法、液滴化方法、カートリッジ及び吐出装置
US20070025869A1 (en) * 2005-07-15 2007-02-01 Gordon John H Fluid Delivery Device
US20080147186A1 (en) * 2006-12-14 2008-06-19 Joshi Ashok V Electrochemical Implant For Delivering Beneficial Agents
US8642664B2 (en) 2007-08-06 2014-02-04 Samir Mitragotri Composition for solubilizing tissue and cells comprising N-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate and polyoxyethylene (10) cetyl ether
WO2009048681A2 (en) * 2007-08-06 2009-04-16 The Regents Of The University Of California Methods of tissue-based diagnosis
US8609041B2 (en) 2007-08-06 2013-12-17 Samir Mitragotri Apparatus for solubilizing tissue
US8389582B2 (en) * 2007-08-06 2013-03-05 Samir Mitragotri Composition for solubilizing tissue comprising 3-(decyl dimethyl ammonio) propane sulfonate and tetraethylene glycol dodecyl ether
US9814422B2 (en) 2007-08-06 2017-11-14 The Regents Of The University Of California Compositions for solubilizing cells and/or tissue
DE102008034098A1 (de) * 2008-07-21 2010-02-04 Lts Lohmann Therapie-Systeme Ag Zubereitung und lontophoretische Vorrichtung für die transdermale Anwendung von Wirkstoffen
CN102421576B (zh) 2009-05-15 2017-04-19 巴塞尔聚烯烃意大利有限责任公司 聚合物颗粒的防粘连处理工艺
AU2011345942B2 (en) * 2010-12-22 2016-03-10 Teikoku Seiyaku Co., Ltd. Electrode pad for iontophoresis
ES2755801R1 (es) * 2018-06-29 2020-04-29 Teixidor Marta Tomas Metodo de fijacion de compresas desechables y protegeslips

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153689A (en) 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
US4141359A (en) 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4250878A (en) 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
JPS5810066A (ja) 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
GB2127689B (en) 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4568343A (en) 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4722726A (en) 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
EP0303713B2 (de) 1987-02-23 1997-07-30 Shiseido Company Limited Perkutaner absorptionspromotor und dermatologische zusammensetzung für externe anwendung
US4994439A (en) 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
US5374241A (en) * 1989-07-21 1994-12-20 Iomed, Inc. Electrodes for iontophoresis
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物
EP0804155B1 (de) * 1994-07-13 2000-11-08 Alza Corporation Zusammensetzung und verfahren zur förderung von transdermaler elektrotransport-darreichung

Also Published As

Publication number Publication date
ES2137551T3 (es) 1999-12-16
DE69512083T2 (de) 2000-03-30
DE69512083D1 (de) 1999-10-14
AU4129696A (en) 1996-06-17
EP0793517B1 (de) 1999-09-08
EP0793517A1 (de) 1997-09-10
US6328728B1 (en) 2001-12-11
WO1996015826A1 (en) 1996-05-30
JPH10509072A (ja) 1998-09-08

Similar Documents

Publication Publication Date Title
ATE184206T1 (de) Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport
MX165338B (es) Entrega transdermica electrolitica de polipeptidos
ATE26215T1 (de) Steigerung der intranasalen absorption von calcitonin durch dessen formulierung mit oberflaechenaktiven mitteln.
ATE260691T1 (de) Vorrichtung zur verabreichnung von medikamenten durch elektrotransport
DK111793A (da) Herbicidpræparat, fremgangsmåde til fremstilling heraf samt aktiverende additiv til opblanding med herbicidpræparater
ES2012944A6 (es) Procedimiento y su dispositivo para la admionistracion de farmacos mediante ionoforesis, para tratamiento loco-regionales.
ATE192664T1 (de) Iontophoresevorrichtung zur transdermalen verabreichung von wirkstoffen vom typ anionische oligosaccaride
MX9204304A (es) Dispositivo de suministro transdermico.
DE69517585D1 (de) Elektrotransport-abgabeeinrichtung mit erhöhter wirkstoffabgabe
ATE153648T1 (de) Verwendungen von alpha-hydroxyfettsäuren
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
ATE308999T1 (de) Intrazellulare expression von carboxypeptidase g2 in enzyme-prodrug-therapie
ES2054962T3 (es) Agentes plaguicidas.
PL328003A1 (en) Modulation of cytokin th 1/th 2 expression by means of ribavirin and ribavirin analoques in t lymphocytes
IL104348A (en) Hair preparation containing cysteamine and permanent wave method
ATE258068T1 (de) Zusammensetzung, vorrichtung und verfahren zur verbesserten elektrotransport-wirkstoffabgabe
DK403384A (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
DE69310844D1 (de) Benutzeraktivierte, iontophoretische vorrichtung
DE69903559D1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
DE3271605D1 (en) Improvements in or relating to electrotherapeutic apparatus
ES2120781T3 (es) Dispositivo ionoforetico de administracion transdermica de medicamentos y conjunto desechable que forma parte de tal dispositivo
ES2000033A6 (es) Composicion de bitionol sulfoxido porcedimiento para su fabricacion y metodo de utilizacion de aquella
DK0448299T3 (da) Præparat til forøget hudkoncentration af aktive midler ved iontoforese
ATE279957T1 (de) Vorrichtung zum transport von molekuelen durch die haut
DE3586457D1 (de) Solubilisierungsverfahren im moment der anwendung eines aktiven lipophilen prinzipes in waessriger loesung zum zweck der intravenoesen verabreichung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties